Last Modified: January 17, 2013
Dates: April 25-26, 2013
Location: Santiago, Chile
Sponsoring Group: The American Society of Hematology
Web Page URL: www.hematology.org/calendar_HOALA
Topics Covered: The American Society of Hematology (ASH) invites you to participate in the only official Highlights of ASH in Latin America, presented by the American Society of Hematology (ASH) and the Sociedad Chilena de Hematología, to hear world-renowned experts translate the most influential research from the 54th ASH Annual Meeting and Exposition into cutting-edge patient care.
Objectives: The goal of the Highlights of ASH meeting is to provide highlights of some of the best research updates presented at the ASH Annual Meeting.
Who Should Attend: hematologists, hematologist-oncologists, oncologists, trainees, Allied health professionals, hematopathologists
Continuing Education: Yes
Dec 9, 2014 - The addition of carfilzomib to lenalidomide and dexamethasone improves progression-free survival in patients with relapsed multiple myeloma, according to a study published online Dec. 6 in the New England Journal of Medicine. The findings were released to coincide with the annual meeting of the American Society of Hematology, held from Dec. 6 to 9 in San Francisco.
Dec 14, 2011
May 22, 2015
May 22, 2015